Anti-MEIOC monoclonal antibody

Pre-made anti-MEIOC monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MEIOC/MEIOC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2593-Ab-1/ GM-Tg-hg-IP2593-Ab-2Anti-Human MEIOC monoclonal antibodyHuman
GM-Tg-rg-IP2593-Ab-1/ GM-Tg-rg-IP2593-Ab-2Anti-Rat MEIOC monoclonal antibodyRat
GM-Tg-mg-IP2593-Ab-1/ GM-Tg-mg-IP2593-Ab-2Anti-Mouse MEIOC monoclonal antibodyMouse
GM-Tg-cynog-IP2593-Ab-1/ GM-Tg-cynog-IP2593-Ab-2Anti-Cynomolgus/ Rhesus macaque MEIOC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2593-Ab-1/ GM-Tg-felg-IP2593-Ab-2Anti-Feline MEIOC monoclonal antibodyFeline
GM-Tg-cang-IP2593-Ab-1/ GM-Tg-cang-IP2593-Ab-2Anti-Canine MEIOC monoclonal antibodyCanine
GM-Tg-bovg-IP2593-Ab-1/ GM-Tg-bovg-IP2593-Ab-2Anti-Bovine MEIOC monoclonal antibodyBovine
GM-Tg-equg-IP2593-Ab-1/ GM-Tg-equg-IP2593-Ab-2Anti-Equine MEIOC monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2593-Ab-1/ GM-Tg-hg-IP2593-Ab-2; GM-Tg-rg-IP2593-Ab-1/ GM-Tg-rg-IP2593-Ab-2;
GM-Tg-mg-IP2593-Ab-1/ GM-Tg-mg-IP2593-Ab-2; GM-Tg-cynog-IP2593-Ab-1/ GM-Tg-cynog-IP2593-Ab-2;
GM-Tg-felg-IP2593-Ab-1/ GM-Tg-felg-IP2593-Ab-2; GM-Tg-cang-IP2593-Ab-1/ GM-Tg-cang-IP2593-Ab-2;
GM-Tg-bovg-IP2593-Ab-1/ GM-Tg-bovg-IP2593-Ab-2; GM-Tg-equg-IP2593-Ab-1/ GM-Tg-equg-IP2593-Ab-2
Products NameAnti-MEIOC monoclonal antibody
Formatmab
Target NameMEIOC
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MEIOC monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2593-Ag-1Recombinant multi-species MEIOC/ C17orf104 protein


    Target information

    Target IDGM-IP2593
    Target NameMEIOC
    Gene ID284071,268491,303572,715275,480499,101085508,540078,100064461
    Gene Symbol and SynonymsC11H17orf104,C17orf104,C19H17orf104,C9H17orf104,Gm1564,Gm663,MEIOC,RGD1563746
    Uniprot AccessionA2RUB1
    Uniprot Entry NameMEIOC_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000180336
    Target ClassificationN/A

    The target: MEIOC, gene name: MEIOC, also named as C17orf104. Predicted to be involved in several processes, including gamete generation; germline cell cycle switching, mitotic to meiotic cell cycle; and mRNA stabilization. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.